sNDA

Roche seeks new Lucentis indication

Roche seeks new Lucentis indication

By

The company is seeking a diabetic retinopathy indication.

Company news: Par Pharmaceutical; Gilead

By

Par Pharmaceutical is going private, selling to TPG for $1.9 billion in cash.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters